title: [Postmarketing herbs clinical evaluation should concern about re-evaluating symptoms].
abstract: Re-evaluation of premarketing medicine is a important supplementary of clinical and elementary research. It is a basement that establish the medicine administration supervisition , found and integrity postmarketing washing out mechanism and define reasonable using drug. After drug marketing, we must not only concern on the re-evaluation of herbs security but also focus on evaluating herbs suitable symptom, as well as its dosage and course of treatment, ect. The re-evaluation of symptoms were seen as the core and feature of traditional Chinese medicine's clinical evaluation. It is also seen as hot spot and difficulty of the research . This article try to focus on simply illustrating the necessity and research thinking of re-evaluation symptoms of postmarketing herbs. So we can define the re-evaluation of postmarketing drug's objection, method, and basement. It will provide beneficial experience and reference to re-evaluation symptom of marketed herbs.
authors.affiliation: Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China. hewei7826@yahoo.com.cn
authors.forename: Wei
authors.initials: W
authors.lastname: He
authors.forename: Yanming
authors.initials: Y
authors.lastname: Xie
authors.forename: Yongyan
authors.initials: Y
authors.lastname: Wang
mesh_terms: D002681:China; D002986:Clinical Trials as Topic; D004358:Drug Therapy / Q000592:standards*; D064420:Drug-Related Side Effects and Adverse Reactions; D004365:Drugs, Chinese Herbal / Q000009:adverse effects / Q000592:standards* / Q000627:therapeutic use*; D006801:Humans; D011358:Product Surveillance, Postmarketing
chemical_list: D004365:Drugs, Chinese Herbal